Lung cancer trials in Latvia

3 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  Where

  Riga

  Age

  18 years to 100 years

  People

  750 worldwide

  Run by

  Amgen

  See details and how to joinNCT05920356 · EU 2022-501863-41-00
• Phase 3Taking people
  DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

  Where

  Riga

  Age

  18 years and over

  People

  670 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07472517 · EU 2025-520565-51-00
• No phaseNot yet taking people in Latvia
  Understanding Lung Cancer Related Risk Factors and Their Impact

  Where

  Riga

  Age

  40 years to 80 years

  People

  6,160 worldwide

  Run by

  Biobizkaia Health Research Institute

  See details and how to joinNCT06473870